Blocking the Receptor for Interleukin 10 Protects Mice from Lethal Listeriosis

Abstract
High doses ofListeria monocytogenesovercome the ability of a normal mouse to control the infection, due to massive bacterial replication. Treatment with an anti-interleukin 10 (IL-10) receptor monoclonal antibody prevented the fatal course of infection with high doses of bacteria. This work shows that blocking the receptor for IL-10 may have useful therapeutic applications.

This publication has 10 references indexed in Scilit: